A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

And, as animated as the novel is ― an amalgam of philosophical questions of identity, the aftermath of environmental ...

Yahoo Finance will chronicle the latest news and updates on Trump's tariffs — from the threats to the eventual policy.

Yahoo Finance will chronicle the latest news and updates on Trump's tariffs — from the threats to the eventual policy.

Mask Network, Gomining, NEM, and MANTRA lead today's top crypto gainers, each showcasing strong momentum and intriguing ...

Corporate securities filings this year are littered with glimpses into new businesses risks, from costs related to President ...

Anixa Biosciences (NASDAQ:ANIX – Get Free Report) is expected to be posting its quarterly earnings results before the market ...

While participation in pickleball and other sports is growing, data on returning to play after joint arthroplasty (JA) is ...

Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity. However, their use in the ...

US Bancorp DE increased its holdings in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 8.3% in the fourth quarter, Holdings Channel reports. The firm owned 6,099 shares of the medical instruments ...

The cross-sectional study included adult patients with lower extremity fractures who owned iPhones and had at least six months of post-injury follow up. Participants shared Apple Health data and ...